An update from Cytori Therapeutics today brings good news to Cardiologists Panama City FL who treat patients after they suffer from an acute heart attack. According to the company’s report on their ongoing trial, patients who are treated with stem cells shortly after a heart attack have significantly less heart damage in a 18 month follow-up.
The Cytori trial, called the APOLLO Trial for Acute Myodcardial Infarction, is studying the safety and efficiency of using stem cell injections as as way to increase blood flow to the heart tissue and minimize damage after a heart attack. The procedure works by taking stem cells from patients abdominal fat tissue and re-infusing it into the affected coronary artery.
Only 6 months after the treatment Cytori reported that those who received the treatment reduced the size of the damaged area by more than twice the amount of the control group (11.7% vs. 6.1%) and at 18 months the respective damages were 11.2% and 4.%
Henricus Duckers, M.D., Ph.D., Interventional Cardiologist, Head of Molecular Cardiology, Thoraxcenter, Erasmus University Hospital explained in a press release that the size of the damage to heart is very important in the long term health of the patient. “There is a strong correlation between infarct size and clinical outcomes,” said Duckers. “This is very encouraging for the field of cardiac cell therapy given that this is one of the first randomized and double-blind trials to demonstrate sustained improvement in outcomes in heart attack patients as far out as 18 months.”
So far the procedure has had no complications among the participants.
The Cardiovascular Institute is made up of leading cardiologist Panama City FL who are are leading the way in comprehensive cardiovascular care for patients. They are currently a part of the groundbreaking ATTAIN and CHOICE studies.